Effect of COVID-19 Vaccination on Thyroid Disease in 7 Million Adult and 0.2 Million Adolescent Vaccine Recipients - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Impact of COVID-19 Vaccination on Thyroid Disorders in Over 7 Million Adults and 200,000 Adolescents

  • By

  • Sungho Bea

  • Hwa Young Ahn

  • Jieun Woo

  • Ju-Young Shin

  • Sun Wook Cho

  • December 9, 2024

Share

Objective:

To investigate the potential association between COVID-19 vaccination and thyroid diseases using a nationwide cohort in South Korea.

Key Findings:
  • No increased risk of hyperthyroidism recurrence after vaccination.
  • Increased risk of hypothyroidism exacerbation observed post-vaccination.
  • No significant differences in thyroid disease incidence based on age, sex, or vaccine type.
  • No increase in thyroid disease risk in adolescents aged 12 to 17 years.
Interpretation:

The study found an increased risk of exacerbation of hypothyroidism following COVID-19 vaccination, but no significant association with other thyroid diseases, supporting the overall safety of COVID-19 vaccines regarding thyroid health.

Limitations:
  • The study may not account for all confounding factors.
  • Data derived from a single country may limit generalizability.
Conclusion:

COVID-19 vaccination is associated with an increased risk of hypothyroidism exacerbation but not with most other thyroid diseases, contributing to evidence of vaccine safety.

Original Source(s)

Effect of COVID-19 Vaccination on Thyroid Disease in 7 Million Adult and 0.2 Million Adolescent Vaccine Recipients

  • by Sungho Bea, Hwa Young Ahn, Jieun Woo, Ju-Young Shin, Sun Wook Cho

  • December 9, 2024

Related Content

AI Tool Finds More Long COVID Cases Than Codes

Nearly 90% of patients who met algorithmic criteria for postacute sequelae of SARS-CoV-2 infection had at least 1 chronic or potentially chronic condition requiring ongoing clinical management.

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

How Often Is Thyroid Hormone Needed After Hemithyroidectomy?

Nearly 40% of patients initiated thyroid hormone therapy within 2 years of hemithyroidectomy, with higher preoperative thyroid‐stimulating hormone levels and thyroid cancer identifying those at greatest risk.